Protocol No
NEURO-GENENTECH-CIELO
Staff Member
Ahmed Obeidat
Phase
III
Summary
This project is being done to assess the effects, good or bad, of satralizumab in patients with autoimmune encephalitis.
Objective
Satralizumab in NMDAR or LGI1 Enchephalitis
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov